Commentary Open Access
Volume 1 | Issue 2 | DOI: https://doi.org/10.33696/Gastroenterology.1.006

Prognostic Utility of Ferritin Transferrin Ratio in Hepatocellular Carcinoma

  • 1Department of Medicine, Cook County Health and Hospital System, IL, USA
  • 2Division of Gastroenterology and Hepatology, Department of Medicine, Cook County Health and Hospital System, County, Chicago, IL, USA
+ Affiliations - Affiliations

Corresponding Author

Ishaan Vohra, ishaan.vohra@cookcountyhhs.org

Received Date: April 17, 2020

Accepted Date: May 27, 2020


Prognostic factors for hepatocellular carcinoma (HCC) has been a dynamic study section. Different staging systems like TNM (tumor size, node status and metastasis) staging, Barcelona staging, Okuda staging, as well as albumin- bilirubin score, alfa fetoprotein (AFP) and many more are evaluated for prognostication of HCC patients. This is an invited commentary on our previously published paper, where we explored the role of the ratio of serum ferritin and transferrin level (FTR). We concluded that FTR >7.7 is associated with better overall survival and outperformed the Barcelona staging system.


Ferritin, Ferritin Transferrin Ratio, Hepatocellular Carcinoma

Author Information X